Cost-effectiveness and public health impact of using high dose quadrivalent influenza vaccine in the French older adults population.

Fabián P AlvarezL AllardF BianicHélène BricoutPascal CrépeyJ GaillatGaëtan GavazziA MosnierOdile LaunayM C LevantD ProshenskaCaroline de Courville
Published in: Journal of medical economics (2024)
Switching to QIV HD in older adults showed to be cost-effective, with even greater public health benefits at higher coverage rate, regardless the season severity.